Chao Ching Lin

age ~54

from Centerville, OH

Get Report

Also known as:

Chao C Lin
Ching Chao Lin
Chao Ching Goorskey
Chao Ching Lin Goorskey
Chaoching Lin
Chao C Goorskey
Ching Lin Chao
Chaoching Porter

Phone and address:: 5151 Crispy Dr, Dayton, OH 45440
9372911433

Connected to:

Chao Lin Phones & Addresses

5151 Crispy Dr, Dayton, OH 45440 • 9372911433
Centerville, OH
Waynesville, OH
Mattapan, MA
4394 W Apache Trl, Fayetteville, AR 72704 • 4792519502
655 N Whitham Ave #26, Fayetteville, AR 72701
Bristol, TN
Halethorpe, MD
Check, VA

Work

Company:

University of massachusetts boston
Jul 2010
Position:

Human resource payroll clerk

Education

School / High School:

University of Massachusetts Boston- Boston, MA
Sep 2008
Specialities:

Bachelor of Science in Management

Name / Title

Company / Classification

Phones & Addresses

Chao H Lin
Owner

Than Brothers Restaurant
Eating Places

3501 E Biddle St, Baltimore, MD 21213

Chao Qing Lin

HONG KONG BUFFET 88, INC

Chao Liang Lin
President

LIN'S KITCHEN, INC

513A Medford St, Quincy, MA 02171
27 Newbury Ave APT 2, Quincy, MA 02171

Wikipedia

Lin Chao

view source

Professor Lin Chao is a Chinese Brazilian American evolutionary biologist and geneticist. Professor ...

Resumes

Electrical Engineer, Master's In Electrical Engineering Candidate, Case Western Reserve University

view source

Position:

Research Assistant at Case Western Reserve University: Control & Energy Systems Center Lab Cleveland, Ohio

Location:

Cleveland, Ohio

Industry:

Electrical/Electronic Manufacturing

Work:

Case Western Reserve University: Control & Energy Systems Center Lab Cleveland, Ohio - Cleveland/Akron, Ohio Area since Aug 2012
Research Assistant

Education:

Case Western Reserve University 2012 - 2013
Master of Engineering (MEng), Electrical and Electronics Engineering Abilene Christian University, Abilene, Texas 2009 - 2011
Bachelors of Science Engineering, Engineering Management South China University of Technology 2006 - 2009
Bachelor of Engineering (B.Eng.), Electrical and Electronics Engineering

Languages:

English
Cantonese
Mandarin

Chao Lin

view source

Location:

Dayton, OH

Industry:

Translation And Localization

Work:

Chinese Translator

Education:

University of Maryland Baltimore County

Chao Lin

view source

Location:

United States

Chao Lin Quincy, MA

view source

Work:

University of Massachusetts Boston

Jul 2010 to 2000
Human Resource Payroll Clerk W Boston Hotels Human Resource
Boston, MA
Aug 2009 to Aug 2009
Temporary Career Fair Interpreter

Education:

University of Massachusetts Boston
Boston, MA
Sep 2008 to 2000
Bachelor of Science in Management

Us Patents

Crystals Of Hepatitis C Virus Helicase Or Fragments Thereof Comprising A Helicase Binding Pocket
view source
US Patent:

7438920, Oct 21, 2008
Filed:

Apr 30, 1999
Appl. No.:

09/303216
Inventors:

Joseph L. Kim - Natick MA, US
Kurt Morgenstern - Derry NH, US
Paul Caron - Malden MA, US
Chao Lin - Brookline MA, US
Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:

A61K 39/29
A61K 38/43
G01N 33/53
C12N 9/00
US Classification:

4242281, 435 71, 435183, 514 2, 514 12
Abstract:

The invention relates to the X-ray crystal structure of the hepatitis C virus helicase domain. More specifically, the invention relates to crystallized complexes of HCV helicase and an oligonucleotide, to crystallizable compositions of HCV helicase and an oligonucleotide and to methods of crystallizing an HCV helicase-oligonucleotide complex. The invention further relates to a computer programmed with the structure coordinates of the HCV helicase oligonucleotide binding pocket or the HCV helicase nucleotide triphosphate pocket wherein said computer is capable of displaying a three-dimensional representation of that binding pocket.

Hcv Ns3-Ns4A Protease Resistance Mutants
view source
US Patent:

7494660, Feb 24, 2009
Filed:

Oct 27, 2004
Appl. No.:

10/974558
Inventors:

Chao Lin - Winchester MA, US
Kai Lin - Waltham MA, US
Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:

C12N 7/00
C07H 21/04
US Classification:

4242181, 536 231
Abstract:

The present invention is directed to mutants of HCV NS3/4A protease. More particularly, the present invention identifies mutant of HCV NS3/4A protease that are resistant to drug treatment.

Hepatitis C Virus Variants
view source
US Patent:

7705138, Apr 27, 2010
Filed:

Nov 13, 2006
Appl. No.:

11/599162
Inventors:

Chao Lin - Winchester MA, US
Tara Kieffer - Brookline MA, US
Christoph Sarrazin - Hamburg, DE
Ann Kwong - Cambridge MA, US
Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:

C12N 15/57
C12N 15/51
C12N 15/74
C12N 15/79
C12N 9/50
C12P 19/34
US Classification:

536 232, 435 691, 435 9121, 435219, 4352523, 4353201, 536 231, 536 2372
Abstract:

The present invention relates to HCV variants, particularly variants that are resistant to a protease inhibitors such as VX-950. Also provided are methods and compositions related to the HCV variants. Further provided are methods of isolating, identifying, and characterizing multiple viral variants from a patient.

Hcv Ns3-Ns4 Protease Resistance Mutants
view source
US Patent:

7884199, Feb 8, 2011
Filed:

Nov 17, 2008
Appl. No.:

12/272425
Inventors:

Chao Lin - Winchester MA, US
Kai Lin - Waltham MA, US
Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:

C07H 23/00
C12N 7/00
C12Q 1/70
US Classification:

536 2371, 4353201, 435 691, 4352351, 435 6
Abstract:

The present invention is directed to mutants of HCV NS3/4A protease. More particularly, the present invention identifies mutant of HCV NS3/4A protease that are resistant to drug treatment.

Combination Therapy For The Treatment Of Hcv Infection
view source
US Patent:

8258116, Sep 4, 2012
Filed:

May 5, 2008
Appl. No.:

12/598802
Inventors:

Ann Kwong - Cambridge MA, US
Nagraj Mani - Natick MA, US
Yi Zhou - Lexington MA, US
Chao Lin - Winchester MA, US
Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:

A01N 43/04
A61K 31/70
US Classification:

514 49, 514 43, 514 50, 514 51
Abstract:

The present invention relates to therapeutic combinations comprising a protease inhibitor and a polymerase inhibitor for the treatment of HCV. The present invention also relates to therapeutic combinations comprising VX-950 and a polymerase inhibitor. Also within the scope of the invention are methods using the therapeutic combinations of the present invention for treating HCV infection or alleviating one or more symptoms thereof in a patient. The present invention also provides kits comprising the combinations of the present invention.

Hepatitis C Virus Variants
view source
US Patent:

8501450, Aug 6, 2013
Filed:

Mar 5, 2010
Appl. No.:

12/718340
Inventors:

Chao Lin - Winchester MA, US
Tara Kieffer - Brookline MA, US
Christoph Sarrazin - Saarland, DE
Ann Kwong - Cambridge MA, US
Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:

C12N 9/50
C12N 15/51
C12N 15/57
C12N 15/74
C12N 15/79
C12P 19/34
US Classification:

435219, 4352523, 4353201, 536 232, 536 2372
Abstract:

The present invention relates to HCV variants, particularly variants that are resistant to a protease inhibitors such as VX-950. Also provided are methods and compositions related to the HCV variants. Further provided are methods of isolating, identifying, and characterizing multiple viral variants from a patient.

Crystallizable Compositions Comprising A Hepatitis C Virus Ns3 Protease Domain/Ns4A Complex
view source
US Patent:

20020042046, Apr 11, 2002
Filed:

Sep 14, 2001
Appl. No.:

09/952975
Inventors:

Joseph Kim - Natick MA, US
Kurt Morgenstern - Derry NH, US
Chao Lin - Cambridge MA, US
Ted Fox - Maynard MA, US
John Thomson - Belmont MA, US
Assignee:

Vertex Pharmaceuticals, Incorporated
International Classification:

C12Q001/70
C12N009/50
C12N007/00
US Classification:

435/005000, 435/219000, 435/235100
Abstract:

The present invention relates to compositions and crystals of a hepatitis C virus protease in complex with its viral cofactor. This invention also relates to methods of using the structure coordinates of hepatitis C virus protease in complex with a synthetic NS4A to solve the structure of similar or homologous proteins or protein complexes.

Quantitative Assay For Nucleic Acids
view source
US Patent:

20020187488, Dec 12, 2002
Filed:

Jan 30, 2002
Appl. No.:

10/060738
Inventors:

Chao Lin - Brookline MA, US
Anne Kwong - Cambridge MA, US
International Classification:

C12Q001/68
C12P019/34
US Classification:

435/006000, 435/091200
Abstract:

The present invention provides a method of accurately assaying the amount of nucleic acids in a biological source. According to another embodiment, the present invention provides a method of accurately assaying HCV in a biological source. The present invention also provides a method of simultaneously screening the effect of a plurality of compounds on the replication of a whole or part of a genome of a biological source. The present invention provides a method of simultaneously screening the effect of a plurality of compounds on the replication of the whole or part of the HCV genome in a biological source.

Facebook

Chao Lin

view source

Harry Chao Lin

view source

Chao Lin

view source

News

Promising Anti-Cancer Drug Also May Function as COVID-19 Antiviral Therapy

view source

lead author), Robert Scharpf and Paul Winnard. Collaborators from the Virginia Polytechnic Institute and State University are Ivan Akhrymuk (joint study lead author), Kylene Kehn-Hall, Lauren Panny and Amy Smith. Shih-Chao Lin from the National Taiwan Ocean University also contributed to the study.
Date: Sep 08, 2022
Category: Health
Source: Google